Skip to main content

Medical x ray buckys

  
  • dcb (c09-1508-414)
    D336038-25mg
    DCB is an allosteric ligand for the metabotropic glutamate receptor mGluR-5 and displays neutral modulation. DCB does not affect agonist-stimulated mGluR-5 responses, but blocks regulation of the receptor by other allosteric modulators such as DFB
    SKUD336038-25mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-439132
    Pack Size 1 EA
    Quantity:
     
  • dcb (c09-1508-413)
    D336038-1mg
    DCB is an allosteric ligand for the metabotropic glutamate receptor mGluR-5 and displays neutral modulation. DCB does not affect agonist-stimulated mGluR-5 responses, but blocks regulation of the receptor by other allosteric modulators such as DFB
    SKUD336038-1mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-439131
    Pack Size 1 EA
    Quantity:
     
  • dcb (c09-1508-412)
    D336038-100mg
    DCB is an allosteric ligand for the metabotropic glutamate receptor mGluR-5 and displays neutral modulation. DCB does not affect agonist-stimulated mGluR-5 responses, but blocks regulation of the receptor by other allosteric modulators such as DFB
    SKUD336038-100mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-439130
    Pack Size 1 EA
    Quantity:
     
  • bf-168
    B651875-5mg
    BF-168, a candidate probe for PET, is found to specifically recognize both neuritic and diffuse plaques, with a K i of 6.4 nM for Aβ1-42 .In VitroBF-168, a styrylbenzoxazole derivative, is a potent agent that selectively recognizes SPs and NFTs in
    SKUB651875-5mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-336583
    Pack Size 1 EA
    Quantity:
     
  • bf-168
    B651875-50mg
    BF-168, a candidate probe for PET, is found to specifically recognize both neuritic and diffuse plaques, with a K i of 6.4 nM for Aβ1-42 .In VitroBF-168, a styrylbenzoxazole derivative, is a potent agent that selectively recognizes SPs and NFTs in
    SKUB651875-50mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-336582
    Pack Size 1 EA
    Quantity:
     
  • bf-168
    B651875-25mg
    BF-168, a candidate probe for PET, is found to specifically recognize both neuritic and diffuse plaques, with a K i of 6.4 nM for Aβ1-42 .In VitroBF-168, a styrylbenzoxazole derivative, is a potent agent that selectively recognizes SPs and NFTs in
    SKUB651875-25mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-336581
    Pack Size 1 EA
    Quantity:
     
  • bf-168
    B651875-10mg
    BF-168, a candidate probe for PET, is found to specifically recognize both neuritic and diffuse plaques, with a K i of 6.4 nM for Aβ1-42 .In VitroBF-168, a styrylbenzoxazole derivative, is a potent agent that selectively recognizes SPs and NFTs in
    SKUB651875-10mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-336580
    Pack Size 1 EA
    Quantity:
     
  • bf-168
    B651875-100mg
    BF-168, a candidate probe for PET, is found to specifically recognize both neuritic and diffuse plaques, with a K i of 6.4 nM for Aβ1-42 .In VitroBF-168, a styrylbenzoxazole derivative, is a potent agent that selectively recognizes SPs and NFTs in
    SKUB651875-100mg
    MFR. NameAladdin Scientific
    Catalog No. C007B-336579
    Pack Size 1 EA
    Quantity: